Goulet Brigitte, Markovic Yelena, Leduy Lam, Nepveu Alain
Molecular Oncology Group, McGill University Health Center, Montreal, Quebec, Canada H3A 1A1.
Mol Cancer Res. 2008 Apr;6(4):644-53. doi: 10.1158/1541-7786.MCR-07-0268.
Proteolytic processing by cathepsin L generates p110 Cut homeobox 1 (CUX1) at the end of the G(1) phase, whereas an alternative transcript encodes p75 CUX1. These short CUX1 isoforms were reported to be overexpressed in cancer cells, and transgenic mice overexpressing the p75 isoform were found to develop myeloproliferative disease-like myeloid leukemias. In the present study, we report that the neutrophil elastase can also generate a short CUX1 isoform in the MV4;11 acute myeloid leukemia cell line. Proteolytic processing was so efficient that the full-length CUX1 protein was detected only when cells were maintained in the presence of the specific elastase inhibitor III. In agreement with these findings, higher levels of the processed cyclin E isoforms were also detected in MV4;11 cells. Reappearance of full-length cyclin E and CUX1 could be induced upon the treatment of MV4;11 cells with the differentiation inducer phorbol 12-myristate 13-acetate or, unexpectedly, following overexpression of a short recombinant CUX1 protein. In both cases, the mechanism involved transcriptional repression of the neutrophil elastase gene. This result revealed a negative feedback loop whereby CUX1 shuts down the expression of the protease that cleaves it. Overall, the findings in MV4;11 and other cancer cells suggest that various mechanisms are used in cancer to favor the expression of short CUX1 isoforms.
组织蛋白酶L介导的蛋白水解过程在G1期结束时产生p110切割同源框1(CUX1),而另一种转录本编码p75 CUX1。据报道,这些短的CUX1异构体在癌细胞中过表达,并且发现过表达p75异构体的转基因小鼠会发展为骨髓增殖性疾病样髓系白血病。在本研究中,我们报道中性粒细胞弹性蛋白酶也能在MV4;11急性髓系白血病细胞系中产生一种短的CUX1异构体。蛋白水解过程非常高效,以至于只有当细胞在特异性弹性蛋白酶抑制剂III存在的情况下培养时才能检测到全长CUX1蛋白。与这些发现一致,在MV4;11细胞中也检测到了更高水平的加工型细胞周期蛋白E异构体。在用分化诱导剂佛波醇12-肉豆蔻酸酯13-乙酸酯处理MV4;11细胞后,或者出乎意料地,在短重组CUX1蛋白过表达后,全长细胞周期蛋白E和CUX1可能会重新出现。在这两种情况下,机制都涉及中性粒细胞弹性蛋白酶基因的转录抑制。这一结果揭示了一个负反馈环,即CUX1关闭切割它的蛋白酶的表达。总体而言,MV4;11和其他癌细胞中的发现表明,癌症中使用了各种机制来促进短CUX1异构体的表达。